An interdisciplinary research team has developed a groundbreaking continuous glucose monitoring (CGM) system which represents a major advancement in wearable health technology and is set to revolutionise diabetes management.
The OECT-CGM includes a microneedle array for subcutaneous glucose sampling with minimal pain and discomfort, addressing one of the major drawbacks of existing CGM devices, deemed invasive due to the requirement of a needle inserted under the skin, which can cause discomfort. Additionally, a viscoelastic and diffusive hydrogel stabilises the interface between the skin and the device, ensuring the sensor remains secure and effective during use.
The research team believes that their work will push the boundaries of current wearable biosensors, particularly in challenging and complex environments. This advancement is critical for providing accurate and reliable glucose readings essential for effective diabetes management.
【MORE】